$20 Million California Plan Targets Critical Gaps Hampering Cell and Gene Therapies
Approval expected on Monday; proposal publicly released only today
California’s ambitious stem cell agency today unveiled a $20 million proposal that zeros in on “critical knowledge gaps” that have stalled commercialization of cell and gene therapies for terrible diseases that afflict millions of persons worldwide.
The new effort targets human cell research dealing with the central nervous system…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.